Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort study.
作者信息
Hengeveld Paul J, Khader Aaram O, de Bruin Linda H A, Geelen Inge G P, van Baalen Eske A, Jansen Eva, Bouwer Nathalie I, Balak Ömer, Riedl Jurgen A, Langerak Anton W, Westerweel Peter E, Levin Mark-David
机构信息
Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Laboratory Medical Immunology, Erasmus MC, Rotterdam, the Netherlands.
出版信息
Br J Haematol. 2020 Aug;190(4):e201-e204. doi: 10.1111/bjh.16983. Epub 2020 Jul 28.
Abstract
摘要
相似文献
1
Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort study.2019冠状病毒病大流行期间入院患者的血细胞计数和淋巴细胞亚群：一项前瞻性队列研究。
Br J Haematol. 2020 Aug;190(4):e201-e204. doi: 10.1111/bjh.16983. Epub 2020 Jul 28.
2
Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study.铁代谢和 ICU 患者 COVID-19 感染期间的淋巴细胞特征：一项观察性队列研究。
World J Emerg Surg. 2020 Jun 30;15(1):41. doi: 10.1186/s13017-020-00323-2.
3
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.基线 T 淋巴细胞亚群绝对计数可预测 SARS-CoV-2 感染患者的结局和严重程度：一项单中心研究。
Sci Rep. 2021 Jun 17;11(1):12762. doi: 10.1038/s41598-021-90983-0.
4
Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.重症和危重症新型冠状病毒肺炎患者淋巴细胞亚群及相关细胞因子水平的动态变化
BMC Infect Dis. 2021 Jan 18;21(1):79. doi: 10.1186/s12879-021-05792-7.
5
The characteristics and predictive role of lymphocyte subsets in COVID-19 patients.淋巴细胞亚群在 COVID-19 患者中的特征和预测作用。
Int J Infect Dis. 2020 Oct;99:92-99. doi: 10.1016/j.ijid.2020.06.079. Epub 2020 Aug 3.
6
Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity.评估 COVID-19 患者的 SARS-CoV-2 RNA 水平和淋巴细胞/T 细胞计数表明，初始免疫状态是疾病严重程度的主要决定因素。
Med Microbiol Immunol. 2020 Dec;209(6):657-668. doi: 10.1007/s00430-020-00693-z. Epub 2020 Aug 28.
7
Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.淋巴细胞亚群作为 COVID-19 患者严重程度和预后的预测指标。
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211048567. doi: 10.1177/20587384211048567.
8
Lymphocyte Subsets in Defense Against New Pathogens in Patients with Cancer.癌症患者抵御新病原体的淋巴细胞亚群。
MEDICC Rev. 2022 May 16;24(2):26-34. doi: 10.37757/mr2022.v24.n2.5.
9
Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.中性粒细胞与淋巴细胞比值对 COVID-19 的预后意义。
Eur J Clin Invest. 2021 Jan;51(1):e13404. doi: 10.1111/eci.13404. Epub 2020 Sep 25.
10
Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.基于临床病程的 COVID-19 患者死亡风险因素：一项单中心回顾性病例对照研究。
Front Immunol. 2021 Feb 16;12:581469. doi: 10.3389/fimmu.2021.581469. eCollection 2021.
引用本文的文献
1
Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience.瑞德西韦对COVID-19住院患者鼻咽拭子标本中SARS-CoV-2 RNA病毒载量动力学的影响：一项真实病例经验
Microorganisms. 2023 Jan 25;11(2):312. doi: 10.3390/microorganisms11020312.
2
Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection.预测感染新型冠状病毒肺炎（COVID-19）的免疫功能低下儿童和青少年感染严重程度及血清转化的因素。
Front Immunol. 2022 Aug 3;13:919762. doi: 10.3389/fimmu.2022.919762. eCollection 2022.
3
An analysis of hematological, coagulation and biochemical markers in COVID-19 disease and their association with clinical severity and mortality: an Indian outlook.新冠病毒疾病的血液学、凝血及生化标志物分析及其与临床严重程度和死亡率的关联：印度视角
Am J Blood Res. 2021 Dec 15;11(6):580-591. eCollection 2021.
4
mA Regulator-Mediated Methylation Modification Patterns and Characteristics of Immunity in Blood Leukocytes of COVID-19 Patients.mA 调节剂介导的 COVID-19 患者血液白细胞免疫中的甲基化修饰模式和特征。
Front Immunol. 2021 Nov 30;12:774776. doi: 10.3389/fimmu.2021.774776. eCollection 2021.
5
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.基线 T 淋巴细胞亚群绝对计数可预测 SARS-CoV-2 感染患者的结局和严重程度：一项单中心研究。
Sci Rep. 2021 Jun 17;11(1):12762. doi: 10.1038/s41598-021-90983-0.
6
Association of Hematologic biomarkers and their combinations with disease severity and mortality in COVID-19- an Indian perspective.血液生物标志物及其组合与COVID-19疾病严重程度和死亡率的关联——印度视角
Am J Blood Res. 2021 Apr 15;11(2):180-190. eCollection 2021.
7
CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.CD4 和 CD8 淋巴细胞计数作为 SARS-CoV-2 肺炎进展的替代早期标志物：一项前瞻性研究。
Viruses. 2020 Nov 9;12(11):1277. doi: 10.3390/v12111277.
本文引用的文献
1
Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19.血小板减少症与因新冠肺炎住院患者的不良预后独立相关。
Br J Haematol. 2020 Sep;190(5):e276-e279. doi: 10.1111/bjh.16950. Epub 2020 Aug 31.
2
Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis.淋巴细胞减少症与严重的 2019 年冠状病毒病（COVID-19）感染相关：系统评价和荟萃分析。
Int J Infect Dis. 2020 Jul;96:131-135. doi: 10.1016/j.ijid.2020.04.086. Epub 2020 May 4.
3
Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients.冠状病毒（COVID-19）感染患者的淋巴细胞亚群、细胞因子与肺部炎症指数之间的关系。
Br J Haematol. 2020 May;189(3):428-437. doi: 10.1111/bjh.16659. Epub 2020 Apr 20.
4
Hematological findings and complications of COVID-19.COVID-19 的血液学表现及并发症。
Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23.
5
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.新型冠状病毒肺炎外周血淋巴细胞亚群特征变化。
J Infect Dis. 2020 May 11;221(11):1762-1769. doi: 10.1093/infdis/jiaa150.
6
Functional exhaustion of antiviral lymphocytes in COVID-19 patients.新冠病毒肺炎患者抗病毒淋巴细胞的功能耗竭
Cell Mol Immunol. 2020 May;17(5):533-535. doi: 10.1038/s41423-020-0402-2. Epub 2020 Mar 19.
7
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.血小板减少症与严重的 2019 年冠状病毒病（COVID-19）感染相关：一项荟萃分析。
Clin Chim Acta. 2020 Jul;506:145-148. doi: 10.1016/j.cca.2020.03.022. Epub 2020 Mar 13.
8
Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection.淋巴细胞减少型社区获得性肺炎作为重症新型冠状病毒肺炎感染的特征
J Infect. 2020 May;80(5):e23-e24. doi: 10.1016/j.jinf.2020.02.029. Epub 2020 Mar 5.
9
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
10
Prognostic Relevance of Altered Lymphocyte Subpopulations in Critical Illness and Sepsis.危重症和脓毒症中淋巴细胞亚群改变的预后相关性
J Clin Med. 2019 Mar 12;8(3):353. doi: 10.3390/jcm8030353.
Zotero 插件